Reneo Pharmaceuticals, Inc. (RPHM)
NASDAQ: RPHM · IEX Real-Time Price · USD
1.750
+0.090 (5.42%)
At close: May 17, 2024, 4:00 PM
1.700
-0.050 (-2.86%)
After-hours: May 17, 2024, 7:30 PM EDT
Reneo Pharmaceuticals Stock Forecast
RPHM's stock price has decreased by -77.71% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for RPHM stock have an average target of 11.46, with a low estimate of 1.00 and a high estimate of 30. The average target predicts an increase of 554.86% from the current stock price of 1.75.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for RPHM stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1.5 | Hold | Reiterates | $1.5 | -14.29% | May 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $30 → $1.5 | Strong Buy → Hold | Downgrades | $30 → $1.5 | -14.29% | Dec 15, 2023 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $17 → $1.8 | Strong Buy → Hold | Downgrades | $17 → $1.8 | +2.86% | Dec 15, 2023 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $1 | Buy → Hold | Downgrades | $1 | -42.86% | Dec 15, 2023 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 15, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.93
from -2.52
EPS Next Year
-0.57
from -0.93
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | 205.3M |
| Avg | n/a | n/a | 120.6M |
| Low | n/a | n/a | 40.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.63 | -0.55 | 1.51 |
| Avg | -0.93 | -0.57 | 1.47 |
| Low | -1.11 | -0.58 | 1.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.